Watson

BayCare Recognized as Top Health System

Wednesday, July 1, 2020 - 1:07am

CLEARWATER, Fla., June 30, 2020 /PRNewswire/ --BayCare Health System and several of its hospitals today were recognized for their excellence in clinical outcomes, operational efficiency, patient experience, and financial health.

Key Points: 
  • CLEARWATER, Fla., June 30, 2020 /PRNewswire/ --BayCare Health System and several of its hospitals today were recognized for their excellence in clinical outcomes, operational efficiency, patient experience, and financial health.
  • The news comes from IBM Watson Health Health, which lists BayCare in the top 20 percent of large health systems in the country.
  • This is the second year in a row BayCare has been recognized with this honor.
  • The IBM Watson Health 100 Top Hospitals Program's annual studies result in the Fortune/IBM Watson Health 100 Top Hospitals list,IBM Watson Health 50 Top Cardiovascular Hospitalslist andIBM Watson Health 15 Top Health Systems list.

IBM Watson Health Recognizes Top-Performing U.S. Hospitals and Health Systems

Tuesday, June 30, 2020 - 11:30am

The goal of the Fortune/IBM Watson Health 100 Top Hospitals and IBM Watson Health 15 Top Health Systems lists is to identify top performing hospitals and health systems and deliver insights that may help healthcare organizations focus their improvement initiatives on achieving consistent, balanced and sustainable high performance.

Key Points: 
  • The goal of the Fortune/IBM Watson Health 100 Top Hospitals and IBM Watson Health 15 Top Health Systems lists is to identify top performing hospitals and health systems and deliver insights that may help healthcare organizations focus their improvement initiatives on achieving consistent, balanced and sustainable high performance.
  • To determine the hospitals included on the Fortune/IBM Watson Health 100 Top Hospitals list, IBM Watson Health researchers evaluated 3,134 short-term, acute care, non-federal U.S. hospitals.
  • As compared to their peer health systems, the hospitals included on the IBM Watson Health 15 Top Health Systems list had better results on performance indicators intended to measure clinical outcomes, operational efficiency and patient experience.
  • To determine the hospitals included on the IBM Watson Health 15 Top Health Systems list, IBM Watson Health researchers evaluated 332 health systems and 2,492 hospitals that are members of health systems.

Watson Launches New Mobile Storage For Its C9 Furniture System

Monday, June 29, 2020 - 2:00pm

POULSBO, Wash., June 29, 2020 /PRNewswire/ -- Watson , the premier manufacturer of commercial office furniture and public safety dispatch consoles, has launched Olli, a new generation work trolley for its award-winning C9 furniture system.

Key Points: 
  • POULSBO, Wash., June 29, 2020 /PRNewswire/ -- Watson , the premier manufacturer of commercial office furniture and public safety dispatch consoles, has launched Olli, a new generation work trolley for its award-winning C9 furniture system.
  • Olli supports personal storage, mobility, and the C9 system's variable density.
  • "Even before COVID-19, Watson's C9 furniture system was designed to create additional elbow room at the workstation, thanks to our patent-pending power rail which creates the generous distance now required," said Lucas Pearl, VP of Product Development at Watson.
  • As the work companion and home to personal gear, Olli introduces rich functionality to mobile storage.

MATEON IS SELECTED BY IBM WATSON HEALTH FOR THE USE OF IBM CLINICAL DEVELOPMENT SOLUTION AT NO COST FOR PHASE II CLINICAL TRIAL OF OT-101 FOR COVID-19

Wednesday, June 24, 2020 - 12:00pm

The award was made following IBMs review of the program and is designed to help accelerate the upcoming phase II COVID-19 clinical trial.

Key Points: 
  • The award was made following IBMs review of the program and is designed to help accelerate the upcoming phase II COVID-19 clinical trial.
  • IBM is supporting COVID-19 clinical research through an initiative to help support trial sponsors with promising therapeutic and vaccine candidates.
  • We believe that the IBM Clinical Development solution can be extremely valuable in creating the efficiencies needed to accelerate the clinical trial process.
  • The ICD platform offering from IBM Watson Health is a cloud-based, end-to-end clinical development system used by leading CROs and designed to reduce the time and cost of clinical trials.

Mateon is Selected by IBM Watson Health for the Use of IBM Clinical Development Solution at No Cost for Phase II Clinical Trial of OT-101 for COVID-19

Wednesday, June 24, 2020 - 12:00pm

The award was made following IBMs review of the program and is designed to help accelerate the upcoming phase II COVID-19 clinical trial.

Key Points: 
  • The award was made following IBMs review of the program and is designed to help accelerate the upcoming phase II COVID-19 clinical trial.
  • IBM is supporting COVID-19 clinical research through an initiative to help support trial sponsors with promising therapeutic and vaccine candidates.
  • We believe that the IBM Clinical Development solution can be extremely valuable in creating the efficiencies needed to accelerate the clinical trial process.
  • The ICD platform offering from IBM Watson Health is a cloud-based, end-to-end clinical development system used by leading CROs and designed to reduce the time and cost of clinical trials.

iBio Selected by IBM Watson Health for the use of IBM Clinical Development Solution at No Cost to help Support clinical COVID-19 Vaccine Candidates

Wednesday, June 24, 2020 - 11:45am

IBM Watson Health recently began offering its ICD solution to eligible trial sponsor organizations as part of its efforts to help support the medical community to address the COVID-19 pandemic.

Key Points: 
  • IBM Watson Health recently began offering its ICD solution to eligible trial sponsor organizations as part of its efforts to help support the medical community to address the COVID-19 pandemic.
  • IBM Watson Health has received interest in the offering from numerous hospitals, sponsors, contract research organizations and academic institutions, and is currently enabling 15 COVID-19 disease trials.
  • This technology helps to support the rapid and efficient undertaking of clinical trials of iBios COVID-19 vaccine candidates.
  • It also complements our FastPharming Systems core speed, quality and scale-up advantages in the development of vaccines and therapeutics.

IBM Launches Watson Works to Address the Challenges of Returning to the Workplace

Thursday, June 18, 2020 - 1:00pm

Returning people to the workplace during the continuing global pandemic demands new approaches to promote the health, safety and productivity of workers in a privacy-preserving way.

Key Points: 
  • Returning people to the workplace during the continuing global pandemic demands new approaches to promote the health, safety and productivity of workers in a privacy-preserving way.
  • Watson Works provides data-driven insights to help employers make informed decisions on workplace re-entry, facilities management, space allocation and other COVID-related priorities.
  • "We've designed Watson Works to help businesses navigate the workplace with the ongoing COVID-19 health crisis as effectively as possible," said Bob Lord, Senior Vice President, Cognitive Applications, Blockchain and Ecosystems, IBM.
  • Watson Works is a curated set of products based on capabilities in IBM Return-to-Workplace Advisor, IBM TRIRIGA, IBM Watson Care Manager, IBM Maximo Worker Insights and IBM Watson Assistant.

Anaconda and IBM Watson Team to Simplify Enterprise Adoption of AI Open-Source Technologies

Thursday, June 4, 2020 - 4:00pm

AUSTIN, Texas, and ARMONK, New York, June 04, 2020 (GLOBE NEWSWIRE) -- Anaconda, Inc. , provider of the leading Python data science platform, and IBM Watson (NYSE: IBM ) today announced a new collaboration to help simplify enterprise adoption of AI open-source technologies.

Key Points: 
  • AUSTIN, Texas, and ARMONK, New York, June 04, 2020 (GLOBE NEWSWIRE) -- Anaconda, Inc. , provider of the leading Python data science platform, and IBM Watson (NYSE: IBM ) today announced a new collaboration to help simplify enterprise adoption of AI open-source technologies.
  • To help enterprises overcome this challenge, Anaconda Team Edition repository will be integrated with IBM Watson Studio on IBM Cloud Pak for Data, enabling organizations to better govern and speed the deployment of AI open-source technologies across any cloud.
  • Anaconda Repository for IBM Cloud Pak for Data is expected to be available to IBM customers starting June 19, 2020.
  • For more information on Anaconda Repository for IBM Cloud Pak for Data, visit IBM Big Data Hub .

Rigrodsky & Long, P.A. Files Class Action Suit Against Willis Towers Watson Public Limited Company

Thursday, June 4, 2020 - 4:30am

announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Willis Towers Watson Public Limited Company (Willis Towers Watson or the Company) (NASDAQ GS: WLTW ) common stock in connection with the proposed acquisition of Willis Towers Watson by Aon plc (Aon) announced on March 9, 2020 (the Complaint).

Key Points: 
  • announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Willis Towers Watson Public Limited Company (Willis Towers Watson or the Company) (NASDAQ GS: WLTW ) common stock in connection with the proposed acquisition of Willis Towers Watson by Aon plc (Aon) announced on March 9, 2020 (the Complaint).
  • The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Willis Towers Watson, its Board of Directors (the Board), and Aon, is captioned Kent v. Willis Towers Watson Public Limited Company, Case No.
  • On March 9, 2020, Willis Towers Watson entered into an agreement and plan of merger (the Merger Agreement) with Aon.
  • Pursuant to the terms of the Merger Agreement, shareholders of Willis Towers Watson will receive 1.08 newly issued Class A ordinary shares of Aon for each share of Willis Towers Watson common stock they own (the Proposed Transaction).

Deshaun Watson Partners with Ashley HomeStore to Launch 4 Books for #4 Summer Reading Challenge

Thursday, May 28, 2020 - 3:05pm

"4 Books for #4," the Deshaun Watson Foundation Summer Reading Challenge, is open to Houston-area children ages 5 18.

Key Points: 
  • "4 Books for #4," the Deshaun Watson Foundation Summer Reading Challenge, is open to Houston-area children ages 5 18.
  • To qualify for the summer reading challenge contest, a child must read four books by August 10.
  • Simply text READ4 to 797979 for more information and to register for Deshaun's Summer Reading Challenge, 4 Books for #4.
  • "Our promise to children aligns with the Deshaun Watson Foundation's commitment to education," notes Chad Spencer, CEO of Ashley HomeStore in Houston.